These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 3901715
1. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation. Anderson JL, Reid PR, Platia EV, Akhtar M, Ruskin JN, Schaal SF, Jueng P, Long RA, Wenger TL. Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715 [Abstract] [Full Text] [Related]
10. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636 [Abstract] [Full Text] [Related]
14. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram. Turitto G, Fontaine JM, Ursell S, Caref EB, Bekheit S, el-Sherif N. Am J Med; 1990 Jan 25; 88(1N):35N-41N. PubMed ID: 2368762 [Abstract] [Full Text] [Related]
16. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs. Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML. Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926 [Abstract] [Full Text] [Related]
17. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug. Nalos PC, Gang ES, Mandel WJ, Myers MR, Oseran DS, Lass Y, Peter T. Am Heart J; 1988 Jan 01; 115(1 Pt 1):108-14. PubMed ID: 3336965 [Abstract] [Full Text] [Related]
18. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Wyndham CR, Pratt CM, Mann DE, Winkle RA, Somberg J, de Maria AN, Josephson ME. Am J Cardiol; 1987 Oct 16; 60(11):67F-72F. PubMed ID: 3310588 [Abstract] [Full Text] [Related]
19. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM, Lee JT, Woosley RL, Echt DS. Circulation; 1989 Nov 16; 80(5):1247-58. PubMed ID: 2805262 [Abstract] [Full Text] [Related]